Goldman Sachs starts coverage on ResMed with "buy" rating
Go back to Goldman Sachs starts coverage on ResMed with "buy" rating| RESMED, Inc. (NYSE: RMD) | Delayed: 227.65 -1.54 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.19 | 52 Week High | $70.90 | |||
| Open | $225.91 | 52 Week Low | $50.77 | |||
| Day High | $228.49 | P/E | 102.09 | |||
| Day Low | $225.12 | EPS | $2.23 | |||
| Volume | 483,443 | |||||
| Resmed, Inc. (AMEX: RSMDF) | Delayed: 24.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.53 | 52 Week High | $6.68 | |||
| Open | $24.53 | 52 Week Low | $5.13 | |||
| Day High | $24.53 | P/E | N/A | |||
| Day Low | $24.53 | EPS | $0.00 | |||
| Volume | 1 | |||||
